Key Takeaways
- • Warburg Pincus has launched an auction of TRC Companies targeting a sale price exceeding $3 billion including debt, with Harris Williams, UBS, and AEC Advisors managing the process.
- • TRC Companies, founded in 1969, provides outsourced project management and engineering services across infrastructure, power, utilities, and real estate sectors; Warburg acquired the company from New Mountain Capital in 2021.
- • The TRC sale represents one of several major exits in Warburg Pincus's 2025 portfolio, with the firm having returned more than $10 billion to investors year-to-date through dispositions including Modernizing Medicine ($5.3 billion), Sundyne ($2.2 billion), and Neogov ($3 billion-plus).
- • The sale underscores Warburg's aggressive exit strategy despite subdued mid-market private equity dealmaking conditions; broader PE activity remains only marginally ahead of 2024 levels according to Dealogic data analyzed by Ropes & Gray.
- • The firm is also exploring sales of additional healthcare software assets including GHX and Ensemble Health Partners, signaling continued portfolio optimization and capital return acceleration.
Summary
Warburg Pincus has initiated the sale process for TRC Companies, targeting a transaction valuation exceeding $3 billion including debt. The New York-based private equity firm has retained a syndicate of advisors—Harris Williams, UBS, and AEC Advisors—to conduct the auction, which is attracting interest from a broad pool of potential bidders across strategic and financial buyer categories.
TRC Companies, established in 1969, operates as a provider of outsourced project management and engineering services spanning infrastructure development, power and utilities, and real estate sectors. Warburg Pincus acquired TRC from New Mountain Capital in 2021, and the pending sale represents a planned exit from the four-year holding period.
The TRC transaction exemplifies Warburg Pincus's accelerated exit activity throughout 2025. The firm has returned more than $10 billion in capital to investors this year, driven by several major dispositions. These include the $5.3 billion sale of Modernizing Medicine (electronic health records software), the $2.2 billion divestment of Sundyne (pump manufacturer) to Honeywell, and the sale of HR software group Neogov to EQT Partners and Canada Pension Plan Investment Board for more than $3 billion. Warburg is additionally exploring sales of healthcare software platforms GHX and Ensemble Health Partners, signaling continued portfolio rationalization and investor capital returns.
The TRC sale occurs within a broader context of constrained mid-market private equity exit activity. Despite a recent rebound in dealmaking following U.S. tariff policy adjustments, mid-market PE exits remain subdued, with current-year activity tracking only marginally ahead of 2024 levels according to Dealogic data reviewed by Ropes & Gray. Warburg's aggressive divestment posture thus positions the firm as an outlier among peers navigating a cautious exit environment.
TRC Companies, established in 1969, operates as a provider of outsourced project management and engineering services spanning infrastructure development, power and utilities, and real estate sectors. Warburg Pincus acquired TRC from New Mountain Capital in 2021, and the pending sale represents a planned exit from the four-year holding period.
The TRC transaction exemplifies Warburg Pincus's accelerated exit activity throughout 2025. The firm has returned more than $10 billion in capital to investors this year, driven by several major dispositions. These include the $5.3 billion sale of Modernizing Medicine (electronic health records software), the $2.2 billion divestment of Sundyne (pump manufacturer) to Honeywell, and the sale of HR software group Neogov to EQT Partners and Canada Pension Plan Investment Board for more than $3 billion. Warburg is additionally exploring sales of healthcare software platforms GHX and Ensemble Health Partners, signaling continued portfolio rationalization and investor capital returns.
The TRC sale occurs within a broader context of constrained mid-market private equity exit activity. Despite a recent rebound in dealmaking following U.S. tariff policy adjustments, mid-market PE exits remain subdued, with current-year activity tracking only marginally ahead of 2024 levels according to Dealogic data reviewed by Ropes & Gray. Warburg's aggressive divestment posture thus positions the firm as an outlier among peers navigating a cautious exit environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.